Global Diabetic Neuropathy Market 2014-2018

Price :
Published : May-2014
No. of Pages : 55

Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized by progressive damage to the neuronal myelin sheath, which slows down nerve conduction velocity. Axonal damage associated with diabetic neuropathy decreases nerve action potential below normal physiological level, which inhibits neuronal signal transmission. About 60 to 70 percent of the diabetic population develops neuropathy, with a considerable number of cases going undiagnosed during the initial years of progression. Disease management should start with the initial diagnosis of diabetes, from educating patients to giving them regular check-ups. Diabetic neuropathy treatment involves bringing blood glucose levels within the normal range to check for further nerve damage and also additional treatment to provide symptomatic relief. Alternative therapies, which help in managing pain, such as biofeedback, meditation, acupuncture or other relaxation techniques can also be used.

TechNavio’s analysts forecast the Global Diabetic Neuropathy market will grow at a CAGR of 8.41 percent over the period 2014-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Diabetic Neuropathy market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various pain management drugs administered to relieve the pain symptoms associated with diabetic neuropathy. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Diabetic Neuropathy market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio’s report, the Global Diabetic Neuropathy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Diabetic Neuropathy market landscape and its growth prospects in the coming years.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Eli Lilly and Co.
  • Janssen Pharmaceuticals Inc.
  • Pfizer Inc.

Other Prominent Vendors

  • Actavis plc
  • Cephalon Inc.
  • MEDA Pharma GmbH & Co. KG

Key Market Driver

  • Increasing Global Diabetic Population.
  • For a full, detailed list, view our report.

Key Market Challenge

  • High Failure Rate in Clinical Trials.
  • For a full, detailed list, view our report.

Key Market Trend

  • Increasing R&D Activities.
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Therapeutics
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Pulmonary Hypertension – Global Market Research 2015-2019

Pulmonary hypertension is a rare disorder that affects the pulmonary arteries carrying deoxygenated blood to the lungs from the heart. The narrowing or blockage of pulmonary arteries will lead to pulmonary hypertension. Symptoms of the disease do not occur until the disease becomes severe. Certain causes of pulmonary hypertension include emphysema, connective tissue disorders, blood clots in lungs, and sleep apnea. Pulmonary hypertension may sometimes lead to several chronic illnesses, such as kidney failure (renal failure), heart failure, aneurysm, heart attack, or, stroke. Endothelin receptor antagonists, prostacyclin analogs, phosphodiesterase inhibitors, and sGC stimulators are popular drug therapeutic classes available for the treatment of pulmonary hypertension. The analysts forec......

Epilepsy Drugs Market in Europe – Market Analysis 2015-2019

Epilepsy refers to a spectrum of brain disorders manifested by benign to severe, disabling, and life-threatening symptoms. It is caused by factors ranging from brain malformations and tumors to meningitis, high-risk pregnancies, and trauma during birth. When the underlying cause of the disease is unidentified, as is witnessed in the majority of cases, it is known as idiopathic epilepsy. An imbalance between the inhibitory and excitatory signals of the brain, leading to a sudden onset of excitation, results in seizures. The analysts forecast epilepsy drugs market in Europe to grow at a CAGR of 3.22% over the period 2014-2019. Covered in this report The report includes the present scenario and the growth prospects of the epilepsy drugs market in Europe for the period 2015-2019. To c......

Global Digital Health Market – Market Research 2015-2019

During the last few years, the digital technology has revolutionized several industries such as banking, manufacturing, retail, and telecommunication. These industries have been experiencing several changes in their process and policies impacting the entire eco-system through partners, vendors, suppliers, and most importantly through end-users. The healthcare industry was no different to this trend, witnessing phenomenal changes. This is indicated by the increasing adoption of digital health platforms such as mobile health, telehealth, EMR, and other wireless technologies. Genomics, sensor technology, wireless devices, networks, and the internet are the essential elements of digital health technology. Digital health platforms help healthcare organizations to monitor patients remotely, incr......

Global Hemophilia A Market 2015-2019

Hemophilia is a rare bleeding disorder caused by deficiency of clotting factors such as VIII and IX. It is an X-linked recessive disorder, which is more prevalent in males than in females. It is estimated that it affects around 400,000 people per year. The two major types of hemophilia are A and B. Hemophilia A, also called as classical hemophilia or factor VIII deficiency hemophilia, is caused by deficiency of clotting factor VIII. It is transmitted genetically from parent to child during birth. Recombinant clotting factors or plasma-derived clotting factors are being developed for the treatment of this disorder. The analysts forecast global hemophilia A drugs market to grow at a CAGR of 6.25% over the period 2014-2019. Covered in this report This report covers the current scenar......

Global Hemophilia B Market 2015-2019 – Industry Analysis

Hemophilia B, also called the Christmas disease, is a blood coagulation disorder due to the deficiency or improper function of factor IX. It is inherited in an X-linked recessive pattern. This disorder is more prevalent in males than in females. Factor replacement therapies, mainly recombinant, are used in the treatment. The analysts forecast global hemophilia B market to grow posting a CAGR of 4.18% over the period 2014-2019. Covered in this report The report includes the present scenario and the growth prospects of the global hemophilia B market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of hemophilia B. The report, Global Hemophilia B Market 2015-2019, has been prepared based on an......

Global HER2-Negative Breast Cancer Market 2015-2019

HER2-negative breast cancer is a subtype of breast cancer and is the condition when the HER2 is expressed less in the tumor. According to the American Society of Clinical Oncology, most of the patients with breast cancer are known to have HER2-negative breast cancer. HER2-negative breast cancer patients can also be hormone receptor positive (HR+). The HER2 protein is found on the outer surface of the breast cells, and the hormone receptors are found inside breast cells. The cancers that have detectable hormone receptors are known as HR+ breast cancer, and those with HER2-negative have a low level of HER2 gene or the HER2 protein. HER2-negative breast cancer can also be HR+ and then the most preferred therapy is hormone therapy. These patients can be treated with chemotherapy or targeted......

Global Liver Diseases Therapeutics Market 2015-2019

Liver diseases are of different types such as hepatitis, liver cancer, non-alcoholic fatty liver disease, and liver cirrhosis. Hepatitis is the largest segment among these diseases, of which hepatitis C is the biggest and fastest growing segment. The liver diseases caused by viral infections, alcoholism, obesity, diabetes, among many other reasons. Some of the diseases are not curable such as liver cirrhosis or non-alcoholic fatty liver disease, and are usually not diagnosed early. This leads to the substantial damage of the liver, which proves to be life-threatening. Some types of hepatitis are preventable or treatable by using vaccines and indicated drugs. The analysts forecast global liver diseases therapeutics market to grow at a CAGR of 15.61% over the period 2014-2019. Covered ......

Global BioPharma Cold Chain Packaging Market 2015-2019

Packaging of products is the process of enclosing them for the purpose of their distribution, storage, sale, and use. Packaging also helps advertise a product in a better way and protect it from damage during transportation. Biopharma products are called as biological medical products, such as blood or blood components, vaccines, and tissues. These products require packaging to ensure their safety during transportation, to maintain sterility, and to prevent breakage or spillage and contamination. There are three types of packaging used for enclosing these products: primary, secondary, and tertiary. The analysts forecast global biopharmaceutical cold chain packaging market to grow at a CAGR of 4.14% over the period 2014-2019. Covered in this report This report covers the present sc......

Global Cephalosporin Drugs Market 2015-2019

Cephalosporins are bactericidal antibiotics and act by inhibiting cell wall synthesis. They inhibit a wide variety of gram-positive and gram-negative bacteria. They are considered broad-spectrum antibiotics with similar activities to those of ampicillin. They are sometimes grouped into "generations" by their antimicrobial properties. Cephalosporin drugs can be grouped into five classes or generations. The gram-negative antimicrobial property significantly increases with each newer generation of cephalosporin. The analysts forecast global cephalosporin drugs market to grow at a CAGR of 3.21% over the period 2014-2019. Covered in this report In this report, Technavio covers the present scenario and growth prospects of the global cephalosporin drugs market for 2015-2019. To calculate......

Global Healthcare IT Spending – Market Analysis 2015-2019

Healthcare enterprises worldwide have become increasingly dependent on technology and various IT products, solutions, and services to run their business and drive revenue growth. Healthcare IT systems improve the quality and efficiency of the services delivered in the healthcare industry. IT in healthcare is essential to develop a secure environment for patient data storage and maintain a uniform flow of information. These services help reinvent organizations by facilitating the development of more cost-effective structures and centralization of their processes. Both the private and public sector's healthcare organizations are engaging in projects that depend heavily on IT. Private companies in particular are spending more on IT, and this trend is expected to continue during the forecast p......